IMVT
Immunovant, Inc. · Healthcare
CEO Peter Salzmann sold $480K of Immunovant, Inc.
Sold$480,052
$31.86Price
15,068Shares
−1%Stake
What IMVT did after the filing
- The stock from Fri, Aug 23 close, $32.42
- −9.3%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Oct 7 close.
Traded Wed, Aug 21. Filed Fri, Aug 23, 12:07 PM ET, during the session. Returns use the Aug 23 close and the Oct 7 close. Not investment advice.